Literature DB >> 3345930

Intestinal permeability to polyethyleneglycol 600 in Crohn's disease. Peroperative determination in a defined segment of the small intestine.

G Olaison1, P Leandersson, R Sjödahl, C Tagesson.   

Abstract

Ileal permeability to different sized polyethyleneglycols (590-942 dalton PEG) was investigated peroperatively in 11 patients with Crohn's disease and seven with colonic carcinoma. A 15 cm ileal segment was converted into a tied loop, in which the PEG's were deposited. Absorption from the ileal segment was then measured as six-hour urinary recovery of the PEg dose. Polyethyleneglycol absorption in Crohn's disease was greater than in cancer patients and similar throughout the weight range, but in the cancer patients it was inversely proportional to molecular weight. Thus there was significantly greater absorption of the higher weights (greater than or equal to 678 dalton) in the Crohn's, than in the cancer patients. The apparently increased permeability of the small intestine in Crohn's disease may be an important factor in its pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3345930      PMCID: PMC1433310          DOI: 10.1136/gut.29.2.196

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  17 in total

1.  Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). II. Application to normal and abnormal permeability states in man and animals.

Authors:  V S Chadwick; S F Phillips; A F Hofmann
Journal:  Gastroenterology       Date:  1977-08       Impact factor: 22.682

2.  Immune complexes in ulcerative colitis and Crohn's disease.

Authors:  H J Hodgson; B J Potter; D P Jewell
Journal:  Clin Exp Immunol       Date:  1977-08       Impact factor: 4.330

3.  Decreased gastrointestinal absorption of peroral polyethyleneglycols (PEG 1000) in Crohn's disease. A sign of jejunal abnormality.

Authors:  G Olaison; R Sjödahl; C Tagesson
Journal:  Acta Chir Scand       Date:  1987

Review 4.  Uptake and transport of macromolecules by the intestine. Possible role in clinical disorders.

Authors:  W A Walker; K J Isselbacher
Journal:  Gastroenterology       Date:  1974-09       Impact factor: 22.682

5.  Histopathology of Crohn's disease.

Authors:  B S Morson
Journal:  Proc R Soc Med       Date:  1968-01

6.  The pathogenesis of Crohn's disease.

Authors:  M Ward
Journal:  Lancet       Date:  1977-10-29       Impact factor: 79.321

7.  The "early" ulcerative lesion of Crohn's disease: correlative light- and scanning electron-microscopic studies.

Authors:  R R Rickert; H W Carter
Journal:  J Clin Gastroenterol       Date:  1980-03       Impact factor: 3.062

8.  Selectivity of small intestinal exudate in celiac disease and Crohn's disease.

Authors:  J G Kingham; C A Loehry
Journal:  Am J Dig Dis       Date:  1978-01

9.  Intestinal permeability in children with Crohn's disease and coeliac disease.

Authors:  A D Pearson; E J Eastham; M F Laker; A W Craft; R Nelson
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-03

10.  Passage of molecules through the wall of the gastrointestinal tract. Intestinal permeability to polyethyleneglycol 1 000 in patients with Crohn's disease.

Authors:  R Heuman; R Sjödahl; C Tagesson
Journal:  Acta Chir Scand       Date:  1982
View more
  14 in total

1.  Elevated basal intestinal mucosal cytokine levels in asymptomatic first-degree relatives of patients with Crohn's disease.

Authors:  Anant VK Indaram; Santa Nandi; Sam Weissman; Sing Lam; Beverly Bailey; Meyer Blumstein; Ronald Greenberg; Simmy Bank
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

2.  PEG-400 excretion in patients with Crohn's disease, their first-degree relatives, and healthy volunteers.

Authors:  D Ruttenberg; G O Young; J P Wright; S Isaacs
Journal:  Dig Dis Sci       Date:  1992-05       Impact factor: 3.199

3.  Antibody (IgG, IgA, and IgM) to baker's yeast (Saccharomyces cerevisiae), yeast mannan, gliadin, ovalbumin and betalactoglobulin in monozygotic twins with inflammatory bowel disease.

Authors:  E Lindberg; K E Magnusson; C Tysk; G Järnerot
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

Review 4.  The immunopathogenesis of Crohn's disease: a three-stage model.

Authors:  Gavin W Sewell; Daniel Jb Marks; Anthony W Segal
Journal:  Curr Opin Immunol       Date:  2009-08-08       Impact factor: 7.486

5.  Enhanced absorption of macromolecules. A secondary factor in Crohn's disease.

Authors:  M Malin; E Isolauri; P Pikkarainen; R Karikoski; J Isolauri
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

6.  Salivary epidermal growth factor plays a role in protection of ileal mucosal integrity.

Authors:  R K Rao; D W Thomas; S Pepperl; F Porreca
Journal:  Dig Dis Sci       Date:  1997-10       Impact factor: 3.199

7.  Increased pulmonary and intestinal permeability in Crohn's disease.

Authors:  A Adenis; J F Colombel; P Lecouffe; B Wallaert; B Hecquet; X Marchandise; A Cortot
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

8.  Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first degree relatives.

Authors:  P Munkholm; E Langholz; D Hollander; K Thornberg; M Orholm; K D Katz; V Binder
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

9.  Impaired intestinal barrier function measured by differently sized polyethylene glycols in patients with chronic renal failure.

Authors:  M Magnusson; K E Magnusson; T Sundqvist; T Denneberg
Journal:  Gut       Date:  1991-07       Impact factor: 23.059

Review 10.  Epithelial Barrier Function in Gut-Bone Signaling.

Authors:  Naiomy Deliz Rios-Arce; Fraser L Collins; Jonathan D Schepper; Michael D Steury; Sandi Raehtz; Heather Mallin; Danny T Schoenherr; Narayanan Parameswaran; Laura R McCabe
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.